- Report
- February 2022
- 110 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- July 2022
- 100 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- September 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- September 2021
- 181 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- April 2023
- 109 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- March 2021
Global
From €4102EUR$4,250USD£3,519GBP
- Report
- October 2018
- 107 Pages
Global
From €4295EUR$4,450USD£3,684GBP
- Report
- August 2023
- 85 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- August 2023
- 117 Pages
Global
From €3500EUR$3,884USD£3,107GBP
- Report
- December 2023
- 132 Pages
Global
From €917EUR$950USD£787GBP
- Report
- April 2023
- 330 Pages
Global
From €5531EUR$5,730USD£4,744GBP
- Report
- May 2021
- 215 Pages
Global
From €5953EUR$6,168USD£5,107GBP
The Corneal Implant market is a subset of the Optical industry, focusing on the development and sale of products used to replace or repair the cornea. Corneal implants are typically used to treat corneal diseases, such as keratoconus, corneal scarring, and corneal dystrophies. These implants are typically made of biocompatible materials, such as collagen, polymethylmethacrylate, and hydrogels.
Corneal implants are typically used in conjunction with other treatments, such as corneal transplantation, laser refractive surgery, and contact lenses. The market for corneal implants is expected to grow in the coming years, driven by the increasing prevalence of corneal diseases and the growing demand for advanced treatments.
Some of the major companies in the Corneal Implant market include Alcon, Bausch + Lomb, Johnson & Johnson, Novartis, and Allergan. Show Less Read more